Let's uncover which stocks are experiencing notable gaps during today's session. Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Which stocks are moving after the closing bell on Friday? The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data Cognition Therapeutics Inc (
NASDAQ: CGTX ) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours.
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns Sonnet BioTherapeutics Holdings Inc. (
NASDAQ: SONN ) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.
Top movers in Thursday's after hours session Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
These stocks are moving in today's pre-market session Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
Cognition Therapeutics Is Targeting A Critical Form Of Dementia Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Why Is Penny Stock Cognition Therapeutics Trading Over 93% On Wednesday? Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional decline in trials.
November’s Small-Cap Treasures: 3 Stocks Poised for Growth Three promising small-cap stocks, poised for growth in healthcare, cybersecurity, and renewable energy, offer compelling investment opportunities for November.
CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q2 2024 CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
